Results 61 to 70 of about 29,751 (242)

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Transcatheter tricuspid valve replacement [PDF]

, 2012
Despite the explosion in the field of transcatheter aortic valve implantations over the last 10 years, only a handful of transcatheter tricuspid valve-in-valve implants have been described to date. This review describes the basic anatomy and pathology of
Weich H.
core  

Hyepereosiniphilic syndrome and COVID-19: 2 case reports

Journal of Cardiothoracic Surgery, 2023
Background Nearly half of the patients with hypereosinophilic syndrome (HES) have cardiovascular involvement, a major cause of mortality. COVID-19 infection can lead to cardiac involvement, negatively impacting the clinical course and prognosis.
Alborz Sherafati, Mehrzad Rahmanian, Roya Sattarzadeh Badkoubeh, Meysam Khoshavi, Morteza Foroumandi, Soheil Peiman, Farhad Shahi, Akram Sardari, Roghayeh Pourkia, Farnoosh Larti   +9 more
doaj   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Emerging Utilization of Transcatheter Tricuspid Valve Replacement in Severe Tricuspid Regurgitation [PDF]

, 2023
Emerging Utilization of Transcatheter Tricuspid Valve Replacement in Severe Tricuspid Regurgitation, Dr. Anas Hashem, RGH IMRP and Dr. Jeremiah Depta, Cardiology Department Objectives: Anatomy and physiology of Tricuspid Valve (TV) Pathophysiology ...
Hashem, Anas, Depta, Jeremiah P
core  

Mid to Long-term Echocardiographic Follow-up of Patients Undergoing Transcatheter Tricuspid Valve-in-Valve Replacement for Degenerated Bioprosthetic Valves: First Single-Center Report from Iran

Journal of Tehran University Heart Center, 2022
Background: Transcatheter tricuspid valve-in-valve (TTViV) replacement has become an alternative treatment in high-risk patients with bioprosthetic valve degeneration.
Mohammad Sahebjam, Alimohammad Haji Zeinali, Kyomars Abbasi, Solmaz Borjian   +3 more
doaj   +1 more source

Simultaneous Transcatheter Mitral and Tricuspid Valve-in-Valve Replacement [PDF]

The Annals of Thoracic Surgery, 2019
After the popularization of transcatheter aortic valve-in-valve replacement, mitral valve-in-valve is being increasingly performed for failing bioprostheses or annuloplasty rings. In the tricuspid position, despite smaller experience, valve-in-valve is also becoming an alternative to high-risk redo tricuspid surgery.
Guillermo, Ventosa-Fernandez, Laura, Vidal, Ruben, Tarrio, Alfredo, Gomez, Vicente, Peral, Jose Ignacio, Saez de Ibarra   +5 more
openaire   +2 more sources

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

Resurgence of the Tricuspid Valve: A Comprehensive Review of Transcatheter Interventions

Indian Journal of Clinical Cardiology
Tricuspid valve, once considered a “forgotten valve,” is experiencing a remarkable resurgence in clinical practice. Previously viewed as a secondary consequence of left-sided heart disease, tricuspid regurgitation is now recognized as an independent ...
Krishna Santhosh Vemuri, Tejaswi Penta, Deepak Sherpally, Bhavanadhar Penta   +3 more
doaj   +1 more source